Abstract
This study was designed to investigate a possible relationship between the effect of aldosterone upon urinary electrolytes and the incorporation of [14C]riboflavin into renal [14C]flavin mononucleotide (FMN) and [14C]flavin adenine dinucleotide (FAD). Adrenalectomized Sprague-Dawley rats that weighed between 185 and 210 g were pretreated with 15 μg/100 g body wt dexamethasone intraperitoneally. 16 h later they were administered aldosterone (1.5 μg/100 g body wt) and [14C]riboflavin (5.0 μCi/200 g body wt). The urethra of each rat was ligated, and the rats were sacrificed by decapitation 3 h later. The urine was aspirated from the bladders of each rat and analyzed for total Na+ and K+ excretion while the kidneys were removed and the formation of [14C]FMN and [14C]FAD was determined for each kidney. There was a significant increase in the formation of renal [14C]FMN and [14C]FAD (27.3 and 14.4%, respectively) after aldosterone treatment. Aldosterone significantly decreased the excretion of Na+ by 50%, and increased that of K+ by 55%.
To determine if the increased incorporation of [14C]riboflavin into renal [14C]FMN and [14C]FAD was an important intermediary step in the aldosterone-induced alterations in urinary Na+ and K+, the riboflavin analogues 7,8-dimethyl-10-formylmethyl isoalloxazine or 7,8-dimethyl-10-(2′-hydroxyethyl) isoalloxazine were given to the animals i.p. to diminish the conversion of riboflavin to FMN by competitively inhibiting the enzyme flavokinase (EC 2.7.1.26). These analogues were found to significantly counteract the decreased urinary excretion of Na+ as a result of aldosterone from 26±9% to 124±58% (SEM) with a dose-related response when administered from 10 to 25 μg/100 g body wt. The same doses of the analogues that significantly increased the urinary output of Na+ when administered simultaneously with aldosterone also significantly decreased the formation of renal [14C]FMN from 15±4 to 38±3% when compared with the effects of aldosterone alone. The analogues exerted no significant effect on the increased urinary excretion of K+ by aldosterone. The analogues alone had no influence on urinary Na+ and K+ output or the formation of renal [14C]FMN and [14C]FAD at the dose levels that we investigated.
These data strongly suggest that the enhanced synthesis of renal FMN and FAD may be a causative factor in the increased reabsorption of Na+ as a result of aldosterone; and, consequently, riboflavin analogues may function as a novel class of antimineralocorticoids.
Full text
PDF








Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Addison R., McCormick D. B. Biogenesis of flavoprotein and cytochrome components in hepatic mitochondria from riboflavin-deficient rats. Biochem Biophys Res Commun. 1978 Mar 15;81(1):133–138. doi: 10.1016/0006-291x(78)91640-6. [DOI] [PubMed] [Google Scholar]
- BARGER A. C., BERLIN R. D., TULENKO J. F. Infusion of aldosterone, 9-alpha-fluorohydrocortisone and antidiuretic hormone into the renal artery of normal and adrenalectomized, unanesthetized dogs: effect on electrolyte and water excretion. Endocrinology. 1958 Jun;62(6):804–815. doi: 10.1210/endo-62-6-804. [DOI] [PubMed] [Google Scholar]
- BESSEY O. A., LOWRY O. H., DAVIS E. B., DORN J. L. The riboflavin economy of the rat. J Nutr. 1958 Feb 10;64(2):185–202. doi: 10.1093/jn/64.2.185. [DOI] [PubMed] [Google Scholar]
- DELUCA C., KAPLAN N. O. Flavin adenine dinucleotide synthesis in animal tissues. Biochim Biophys Acta. 1958 Oct;30(1):6–11. doi: 10.1016/0006-3002(58)90233-6. [DOI] [PubMed] [Google Scholar]
- Ehresmann B., Imbault P., Weil J. H. Spectrophotometric determination of protein concentration in cell extracts containing tRNA's and rRNA's. Anal Biochem. 1973 Aug;54(2):454–463. doi: 10.1016/0003-2697(73)90374-6. [DOI] [PubMed] [Google Scholar]
- Fazekas A. G., Pinto J., Huang Y. P., Chaudhuri R., Rivlin R. S. Age dependence of thyroxine stimulation of riboflavin incorporation into flavin coenzymes in liver and brain. Endocrinology. 1978 Feb;102(2):641–648. doi: 10.1210/endo-102-2-641. [DOI] [PubMed] [Google Scholar]
- Fazekas A. G., Sandor T. Studies on the biosynthesis of flavin nucleotides from 2- 14 C-riboflavin by rat liver and kidney. Can J Biochem. 1973 Jun;51(6):772–782. doi: 10.1139/o73-096. [DOI] [PubMed] [Google Scholar]
- Fazekas A. G., Sandor T. The in vivo effect of adrenorcorticortropin on the biosynthesis of flavin nucleotides in rat liver and kidney. Can J Biochem. 1971 Aug;49(8):987–989. doi: 10.1139/o71-143. [DOI] [PubMed] [Google Scholar]
- Feldman D., Funder J. W., Edelman I. S. Subcellular mechanisms in the action of adrenal steroids. Am J Med. 1972 Nov;53(5):545–560. doi: 10.1016/0002-9343(72)90152-0. [DOI] [PubMed] [Google Scholar]
- Hirashima M., Hayakawa T., Koike M. Mammalian alpha-keto acid dehydrogenase complexes. II. An improved procedure for the preparation of 2-oxoglutarate dehydrogenase complex from pig heart muscle. J Biol Chem. 1967 Mar 10;242(5):902–907. [PubMed] [Google Scholar]
- Klingenberg M. Localization of the glycerol-phosphate dehydrogenase in the outer phase of the mitochondrial inner membrane. Eur J Biochem. 1970 Apr;13(2):247–252. doi: 10.1111/j.1432-1033.1970.tb00924.x. [DOI] [PubMed] [Google Scholar]
- Lifschitz M. D., Schrier R. W., Edelman I. S. Effect of actinomycin D on aldosterone-mediated changes in electrolyte excretion. Am J Physiol. 1973 Feb;224(2):376–380. doi: 10.1152/ajplegacy.1973.224.2.376. [DOI] [PubMed] [Google Scholar]
- Linn T. C., Pelley J. W., Pettit F. H., Hucho F., Randall D. D., Reed L. J. -Keto acid dehydrogenase complexes. XV. Purification and properties of the component enzymes of the pyruvate dehydrogenase complexes from bovine kidney and heart. Arch Biochem Biophys. 1972 Feb;148(2):327–342. doi: 10.1016/0003-9861(72)90151-8. [DOI] [PubMed] [Google Scholar]
- Morris D. J., Berek J. S., Davis R. P. The physiological response to aldosterone in adrenalectomized and intact rats and its sex dependence. Endocrinology. 1973 Apr;92(4):989–993. doi: 10.1210/endo-92-4-989. [DOI] [PubMed] [Google Scholar]
- Ogunmodede B. K., McCormick D. B. Sparing of riboflavin in rats by 6,7-dimethyl-9-(omega-hydroxyalkyl)isoalloxazines. Proc Soc Exp Biol Med. 1966 Jul;122(3):845–847. doi: 10.3181/00379727-122-31266. [DOI] [PubMed] [Google Scholar]
- Ragan C. I., Racker E. Resolution and reconstitution of the mitochondrial electron transport system. IV. The reconstitution of rotenone-sensitive reduced nicotinamide adenine dinucleotide-ubiquinone reductase from reduced nicotinamide adenine dinucleotide dehydrogenase and phospholipids. J Biol Chem. 1973 Oct 10;248(19):6876–6884. [PubMed] [Google Scholar]
- Reed J. K. Studies on the kinetic mechanism of lipoamide dehydrogenase from rat liver mitochondria. J Biol Chem. 1973 Jul 10;248(13):4834–4839. [PubMed] [Google Scholar]
- Rivlin R. S. Regulation of flavoprotein enzymes in hypothyroidism and in riboflavin deficiency. Adv Enzyme Regul. 1970;8:239–250. doi: 10.1016/0065-2571(70)90020-8. [DOI] [PubMed] [Google Scholar]
- Shapiro S., Percin C. J. Thyroid hormone induction of alpha-glycerophosphate dehydrogenase in rats of different ages. Endocrinology. 1966 Dec;79(6):1075–1078. doi: 10.1210/endo-79-6-1075. [DOI] [PubMed] [Google Scholar]
- Tan E. L., Trachewsky D. Effect of aldosterone on flavin coenzyme biosynthesis in the kidney. J Steroid Biochem. 1975 Nov-Dec;6(11-12):1471–1475. doi: 10.1016/0022-4731(75)90199-5. [DOI] [PubMed] [Google Scholar]
- Yang C. S., McCormick D. B. Degradation and excretion of riboflavin in the rat. J Nutr. 1967 Dec;93(4):445–453. doi: 10.1093/jn/93.4.445. [DOI] [PubMed] [Google Scholar]
